Trial intelligence / Profile preview

Continuous femoral nerve block with different ropivacaine concentrations after total knee arthroplasty

ChiCTR-TRC-12002537Phase 4Completed

Sponsor
The First Affiliated Hospital of Wenzhou Medical University
Start
Jan 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of ropivacaine in knee osteoarthritis (OA) (3 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoints: Pain visual analog scale, Physical therapy and 2 more. Started Jan 2012; status: completed.

02

Drugs

ropivacaine
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on ChiCTR-TRC-12002537.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002537.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call